Dysregulated Erythroid Mg 2+ Efflux in Type 2 Diabetes.
Autor: | Ferreira A; Interdisciplinary Centre of Social Sciences (CICS.NOVA), Faculty of Social Sciences and Humanities (NOVA FCSH), Lisbon, Portugal., Rivera A; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States., Wohlgemuth JG; Quest Diagnostics, Secaucus, NJ, United States., Dlott JS; Quest Diagnostics, Secaucus, NJ, United States., Snyder LM; Quest Diagnostics, Secaucus, NJ, United States., Alper SL; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States., Romero JR; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Apr 04; Vol. 10, pp. 861644. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022). |
DOI: | 10.3389/fcell.2022.861644 |
Abstrakt: | Hyperglycemia is associated with decreased Mg 2+ content in red blood cells (RBC), but mechanisms remain unclear. We characterized the regulation of Mg 2+ efflux by glucose in ex vivo human RBC. We observed that hemoglobin A Competing Interests: Authors JW and JD were employed by the company Quest Diagnostics. Authors LS and SA were consultants to Quest Diagnostics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Ferreira, Rivera, Wohlgemuth, Dlott, Snyder, Alper and Romero.) |
Databáze: | MEDLINE |
Externí odkaz: |